[1]
|
赛米•赛麦提, 买买提•依斯热依力, 艾克拜尔•艾力. 肥胖与2型糖尿病关系的研究进展[J]. 中华肥胖与代谢病电子杂志, 2020, 6(2): 130-134.
|
[2]
|
Schuetz, C.A., Ong, S.H. and Blüher, M. (2015) Clinical Trial Simulation Methods for Estimating the Impact of DPP-4 Inhibitors on Cardiovascular Disease. ClinicoEconomics and Outcomes Research, 7, 313-323.
https://doi.org/10.2147/CEOR.S75935
|
[3]
|
Shin, J., Fukuhara, A., Onodera, T., et al. (2017) Regulation of Dipep-tidyl Peptidase-4, Its Substrate Chemokines, and Their Receptors in Adipose Tissue of ob/ob Mice. Hormone and Meta-bolic Research, 49, 380-387.
https://doi.org/10.1055/s-0043-100115
|
[4]
|
Jiang, S., Wu, X., Wang, Y., et al. (2020) The Potential DPP-4 Inhib-itors from Xiao-Ke-An Improve the Glucolipid Metabolism via the Activation of AKT/GSK-3β Pathway. European Journal of Pharmacology, 882, Article ID: 173272.
https://doi.org/10.1016/j.ejphar.2020.173272
|
[5]
|
Nauck, M.A., Kahle, M., Baranov, O., Deacon, C.F. and Holst, J.J. (2017) Addition of a Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, to Ongoing Therapy with the Glucagon-Like Pep-tide-1 Receptor Agonist Liraglutide: A Randomized Controlled Trial in Patients with Type 2 Diabetes. Diabetes, Obesity and Metabolism, 19, 200-207.
https://doi.org/10.1111/dom.12802
|
[6]
|
Zilleßen, P., Celner, J., Kretschmann, A., et al. (2016) Metabolic Role of Dipeptidyl Peptidase 4 (DPP4) in Primary Human (Pre)Adipocytes. Scientific Reports, 6, Article No. 23074. https://doi.org/10.1038/srep23074
|
[7]
|
Rius, J., Guma, M., Schachtrup, C., et al. (2008) NF-κB Links Innate Im-munity to the Hypoxic Response through Transcriptional Regulation of HIF-1α. Nature, 453, 807-811. https://doi.org/10.1038/nature06905
|
[8]
|
Kojta, I., Chacińska, M. and Błachnio-Zabielska, A. (2020) Obesity, Bio-active Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Nutrients, 12, Article No. 1305. https://doi.org/10.3390/nu12051305
|
[9]
|
Del Chierico, F., Manco, M., Gardini, S., et al. (2021) Fecal Microbiota Signatures of Insulin Resistance, Inflammation, and Metabolic Syndrome in Youth with Obesity: A Pilot Study. Acta Diabetologica, 58, 1009-1022.
https://doi.org/10.1007/s00592-020-01669-4
|
[10]
|
Liddle, D.M., Hutchinson, A.L., Wellings, H.R., et al. (2017) Integrated Immunomodulatory Mechanisms through Which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction. Nutrients, 9, Article No. 1289. https://doi.org/10.3390/nu9121289
|
[11]
|
Mortier, A., Gouwy, M., Van Damme, J., Proost, P. and Struyf, S. (2016) CD26/Dipeptidylpeptidase IV—Chemokine Interactions: Double-Edged Regulation of Inflammation and Tumor Biology. Journal of Leukocyte Biology, 99, 955-969.
https://doi.org/10.1189/jlb.3MR0915-401R
|
[12]
|
Lin, Y.-C., Huang, M.-Y., Lee, M.-S., et al. (2018) Effects of Montelukast on M2-Related Cytokine and Chemokine in M2 Macrophages. Journal of Microbiology, Immunology and Infection, 51, 18-26.
https://doi.org/10.1016/j.jmii.2016.04.005
|
[13]
|
买买提∙依斯热依力, 艾克拜尔∙艾力, 买买提艾力•艾则孜, 等. 心理应激对小鼠脂肪组织黄嘌呤氧化酶表达、活性及相关指标的影响[J]. 中国应用生理学杂志, 2019, 35(6): 537-542.
|
[14]
|
Kojta, I., Chacińska, M. and Błachnio-Zabielska, A. (2020) Obesity, Bioactive Lipids, and Adipose Tis-sue Inflammation in Insulin Resistance. Nutrients, 12, 1305.
|
[15]
|
Shen, B., Zhao, C., Wang, Y., et al. (2019) Aucubin Inhibited Lipid Accumulation and Oxidative Stress via Nrf2/HO-1 and AMPK Signalling Pathways. Journal of Cellular and Molecular Medicine, 23, 4063-4075.
https://doi.org/10.1111/jcmm.14293
|
[16]
|
Xie, Y., Zhou, W., Zhong, Z., et al. (2021) Metabolic Syndrome, Hyper-tension, and Hyperglycemia Were Positively Associated with Knee Osteoarthritis, While Dyslipidemia Showed No As-sociation with Knee Osteoarthritis. Clinical Rheumatology, 40, 711-724. https://doi.org/10.1007/s10067-020-05216-y
|
[17]
|
Arner, P., Bernard, S., Appelsved, L., et al. (2019) Adipose Li-pid Turnover and Long-Term Changes in Body Weight. Nature Medicine, 25, 1385-1389. https://doi.org/10.1038/s41591-019-0565-5
|
[18]
|
Kim, C.Y., Kang, B., Suh, H.J. and Choi, H.-S. (2019) Par-thenolide, a Feverfew-Derived Phytochemical, Ameliorates Obesity and Obesity-Induced Inflammatory Responses via the Nrf2/Keap1 Pathway. Pharmacological Research, 145, Article ID: 104259. https://doi.org/10.1016/j.phrs.2019.104259
|
[19]
|
Xin, M., Jin, X., Cui, X., et al. (2019) Dipeptidyl Peptidase-4 In-hibition Prevents Vascular Aging in Mice under Chronic Stress: Modulation of Oxidative Stress and Inflammation. Chemico-Biological Interactions, 314, Article ID: 108842. https://doi.org/10.1016/j.cbi.2019.108842
|
[20]
|
Sharma, A., Singh, S., Ahmad, S., et al. (2021) NOD1 Activation Induces Oxidative Stress via NOX1/4 in Adipocytes. Free Radical Biology and Medicine, 162, 118-128. https://doi.org/10.1016/j.freeradbiomed.2020.11.036
|
[21]
|
Hasegawa, Y., Hayashi, K., Takemoto, Y., et al. (2017) DPP-4 Inhibition with Linagliptin Ameliorates the Progression of Premature Aging in Klotho-/- Mice. Cardiovascular Diabetology, 16, Article No. 154.
https://doi.org/10.1186/s12933-017-0639-y
|
[22]
|
Darsalia, V., Klein, T., Nyström, T. and Patrone, C. (2018) Glu-cagon-Like Receptor 1 Agonists and DPP-4 Inhibitors: Anti-Diabetic Drugs with Anti-Stroke Potential. Neuropharma-cology, 136, 280-286.
https://doi.org/10.1016/j.neuropharm.2017.08.022
|
[23]
|
Lee, M.M.Y., Petrie, M.C., McMurray, J.J.V. and Sattar, N. (2020) How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials. Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 506-522.
https://doi.org/10.1161/ATVBAHA.119.311904
|
[24]
|
Wang, Z., Ka, S.-O., Lee, Y., Park, B.-H. and Bae, E.J. (2017) Butein Induction of HO-1 by p38 MAPK/Nrf2 Pathway in Adipocytes Attenuates High-Fat Diet Induced Adi-pose Hypertrophy in Mice. European Journal of Pharmacology, 799, 201-210. https://doi.org/10.1016/j.ejphar.2017.02.021
|
[25]
|
Ottobelli Chielle, E., de Souza, W.M., da Silva, T.P., Moresco, R.N. and Moretto, M.B. (2016) Adipocytokines, Inflammatory and Oxidative Stress Markers of Clinical Relevance Al-tered in Young Overweight/Obese Subjects. Clinical Biochemistry, 49, 548-553. https://doi.org/10.1016/j.clinbiochem.2016.01.003
|
[26]
|
夏莉, 胡红琳, 戚仁娟, 等. 西格列汀对肥胖大鼠血清内脏脂肪素水平的影响研究[J]. 安徽医学, 2016, 37(3): 262-265.
|
[27]
|
Wang, X., Ke, J., Zhu, Y.-J., Cao, B., Yin, R.-L., Wang, Y., Wei, L.-L., Zhang, L.-J., Yang, L.-Y. and Zhao, D. (2021) Dipeptidyl Peptidase-4 (DPP4) Inhibitor Sitagliptin Alleviates Liver Inflammation of Diabetic Mice by Acting as a ROS Scavenger and Inhibiting the NFκB Pathway. Cell Death Discovery, 7, Article No. 236.
https://doi.org/10.1038/s41420-021-00625-7
|
[28]
|
Shiraki, A., Oyama, J., Shimizu, T. and Node, N. (2022) The DPP4 Inhibitor Linagliptin Exacerbated Heart Failure due to Energy Deficiency via Downregulation of Glucose Absorp-tion and Utilization in Mice. European Heart Journal, 43, Article ID: ehac544.2682. https://doi.org/10.1093/eurheartj/ehac544.2682
|
[29]
|
Li, R., Zeng, X., Yang, M., Xu, X., Feng, J., Bao, L., Xue, B., Wang, X. and Huang, Y. (2021) Antidiabetic Agent DPP-4i Facilitates Murine Breast Cancer Metastasis by Oncogenic ROS-NRF2-HO-1 Axis via a Positive NRF2-HO-1 Feedback Loop. Frontiers in Oncology, 11, Article ID: 679816. https://doi.org/10.3389/fonc.2021.679816
|
[30]
|
Cao, Q., Xu, D., Chen, Y., Long, Y., Dai, F., Gui, L. and Lu, Y. (2021) Sitagliptin Reduces Endothelial Dysfunction and Apoptosis Induced by High-Fat Diet and Palmitate in Thoracic Aortas and Endothelial Cells via ROS-ER Stress- CHOP Pathway. Frontiers in Pharmacology, 12, Article ID: 670389. https://doi.org/10.3389/fphar.2021.670389
|
[31]
|
Ishibashi, Y., Matsui, T., Maeda, S., Higashimoto, Y. and Yamag-ishi, S. (2013) Advanced Glycation End Products Evoke Endothelial Cell Damage by Stimulating Soluble Dipeptidyl Peptidase-4 Production and Its Interaction with Mannose 6-Phosphate/Insulin-Like Growth Factor II Receptor. Cardio-vascular Diabetology, 12, 125.
|